Previous 10 | Next 10 |
Second quarter revenue grew 4.6x year-over-year to $265.4 million U.S. value-based care members grew by 220% year-over-year Adjusted EBITDA Margin of (25.9)% for the quarter, a 60% improvement year-over-year Reiterating full year 2022 revenue guidance of $1.0...
Babylon (NYSE:BBLN) today announced it will host its third ‘Ask The CEO’ webcast featuring Dr. Ali Parsa, the Founder and CEO of Babylon, on August 11 at 1:00 pm EST (10:00 am PST), following the announcement of its second quarter 2022 financial results on August 9. ...
Babylon (NYSE: BBLN) (“Babylon” or the “Company”) today announced it will host a conference call to review the Company’s second quarter 2022 financial results in full on Tuesday, August 9, 2022, at 5:00 PM Eastern Time. A press release announcing t...
Babylon ( NYSE: BBLN ) plans to accelerate its path to profitability through revenue and cost efficiencies, implemented in Q3 and expects effect in Q4. Company is improving its Adjusted EBITDA guidance for FY 2022 from $(295)M or less to $(270)M or less, with forecasted m...
Actions are expected to generate savings of up to $100m per year Revenue guidance is reiterated at $1bn or greater for 2022 Babylon Holdings Limited (NYSE: BBLN) (“Babylon” or the “Company”), one of the world’s fastest growi...
In this podcast, Motley Fool analysts Deidre Woollard and Tim Beyers discuss: Motley Fool contributor Rachel Warren interviews Ali Parsa, CEO of Babylon Holdings (NYSE: BBLN) , a digital-first health service provider. They discuss the company's journey going public and the excit...
Babylon Holdings Limited (NYSE: BBLN) (“Babylon” or the “Company”) today announced the completion of its previously announced exchange offer (the “Exchange Offer”) and consent solicitation (the “Consent Solicitation”) relating to i...
Babylon Holdings Limited (NYSE: BBLN) (“Babylon” or the “Company”) announced today the expiration and results of its previously announced exchange offer (the “Exchange Offer”) and consent solicitation (the “Consent Solicitation”) r...
At the conclusion of the 2022 Russell indexes annual reconstitution, Babylon (NYSE:BBLN) will join the broad-market Russell 3000 Index. Changes are effective after the US market opens on June 27, 2022. Babylon (BBLN) has a market cap of $468.37M. Its shares are down ~4% pre-market a...
Babylon (NYSE:BBLN) is set to join the broad-market Russell 3000 ® Index at the conclusion of the 2022 Russell indexes annual reconstitution, effective after the US market opens on June 27, according to a preliminary list of additions posted June 3. Annual Russell index...
News, Short Squeeze, Breakout and More Instantly...
Babylon Holdings Limited Class A Company Name:
BBLN Stock Symbol:
NYSE Market:
Babylon (NYSE: BBLN) (the “Company”) today announced it will host a conference call to review its first quarter financial results on Wednesday, May 10, 2023, at 8:00 AM Eastern Time. A press release announcing the results will be issued prior to the conference call on Wednesday, May...
Chronic conditions include diabetes, hypertension, anxiety, depression, low back pain, and prenatal care Babylon’s technology will collect and analyze data to monitor patients in real-time Personalized care teams will tailor evidence-based programs for each member C...
Revenue grew 3.5x YoY, to $1.11 billion, exceeding guidance Cost of Care Delivery (COCD) Margin in the U.K. already profitable 1 , with U.S. Clinical services also expecting COCD profitability in early 2023 Key U.S. VBC contracts delivered profitable Medical Margins 2 in t...